What we do
About us
News & events
Investors
Careers
What we do
About us
News & events
Investors
Overview
Press releases
Events & presentations
Corporate Governance
Shareholder & stock info
Financial reports
Financial calendar
Rights Issue and Directed Issue 2023
Careers
Back
Back
Invitation to presentation of Mendus’ year-end report for 2023
8:00:00 AM
Keep reading
Mendus announces ethics committee approval for the AMLM22-CADENCE trial with lead product vididencel in AML
Read